News

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its ...
The data from 2018 till August 4, 2025 show a decline in the number of suspected as well as confirmed rabies cases ...
President Trump signed an executive order pushing a policy of encouraging civil commitment of mentally ill homeless people, ...
If you're interested in losing facial fat around your chin, cheeks, and neck, addressing overall weight loss and factors that ...
The Secret Link between Food and Mood offers a holistic approach to mental well-being, revealing how nutrition can transform ...
Moderate coffee intake and both moderate and high tea consumption are associated with a slower decline in fluid intelligence ...
Researchers from the School of Chemistry have found a new way to remove a common pollutant from water using controlled waves ...
Researchers found that brain support cells produce a chemical that suppresses appetite, and they created a modified version ...
Baltimore's recent decrease of homicides and shootings came about thanks, in part, to partnerships and programs that help track situations in real time.
The cost of inaction is immeasurable when lives and livelihoods are at stake. It is our duty to push the safety envelope as ...
US FDA approves Apellis Pharma’s Empaveli as the first C3G and primary IC-MPGN treatment for patients 12 and older: Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [I ...
Also today, Rhythm announced that Alastair Garfield, Chief Scientific Officer, and David Connolly, Head of Investor Relations, will participate in a fireside chat at the upcoming Canaccord Genuity ...